FibroGen: Q4 Earnings Snapshot

Associated Press Finance
1 min read
0
In this article:

SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — FibroGen Inc. (FGEN) on Monday reported a loss of $56.2 million in its fourth quarter.

The San Francisco-based company said it had a loss of 57 cents per share.

The biotech drug developer posted revenue of $27.1 million in the period.

For the year, the company reported a loss of $284.2 million, or $2.92 per share. Revenue was reported as $147.8 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FGEN at https://www.zacks.com/ap/FGEN

Advertisement

Recommended Stories